NCT00003993 2015-04-29Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1 Completed24 enrolled
NCT00002504 2011-05-12Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic CancerHoag Memorial Hospital PresbyterianPhase 2 Completed